Search

everythinglearnresearchcommunity

for

Search:↓

LGBT individuals have unique skin health needs, including higher STD risks and side effects from gender-affirming treatments, requiring dermatologists to offer knowledgeable and culturally competent care.

Most treatments for lichen planopilaris were found to be generally unsatisfactory.

Skin symptoms are important for diagnosing and managing juvenile-onset systemic lupus erythematosus and usually get better with treatment.

Scarring alopecias are complex hair loss disorders that require early treatment to prevent permanent hair loss.

Both treatments for pemphigus foliaceus in dogs are effective, but combination therapy has more side effects.

People with atopic dermatitis are more likely to develop other skin conditions due to shared genetics and immune pathways.

Low-potency steroids can cause serious side effects in people with skin conditions like Netherton syndrome.

Some treatments for folliculitis decalvans work well, with tetracyclines and a mix of rifampicin and clindamycin being most effective.

Oral valganciclovir improved a patient's skin condition caused by immunosuppression.

Some drugs can cause hair loss, excessive growth, or color changes, often reversible but sometimes permanent.

Bee venom might be a good alternative treatment for various skin conditions because it has many healing properties.

New treatments for a chronic skin condition show promise, but individualized plans are crucial due to varying responses.

Intralesional triamcinolone acetonide is effective for treating patchy hair loss, and dermoscopy helps detect treatment response and side effects early.

Autoimmune diseases can cause hair loss, and early treatment is important to prevent permanent damage.

Alopecia Areata is a complex, unpredictable autoimmune hair loss condition with limited treatment options and a significant psychological impact.

ALA-PDT is effective and safe for chronic X-ray dermatitis, providing complete or partial remission.

Early treatment of superficial fungal infections in immunocompromised patients is crucial.

Some congenital hair disorders improve in childhood or with treatments like minoxidil and retinoids, while others like Netherton syndrome and trichothiodystrophy have a poor prognosis.

Certain leukemia drugs can cause severe skin reactions that may require stopping treatment.

Prominin-1 expressing cells in the dermal papilla help regulate hair follicle size and communication but don't aid in skin repair.

Different hair growth problems are caused by genetic issues or changes in hair growth cycles, and new treatments are being developed.

The document concludes that treating tough skin disease in lupus involves sun protection, steroids, antimalarials, and various other therapies chosen based on individual risks and benefits.

Longer hair loss leads to more severe CCCA; early treatment and avoiding damaging hairstyles help regrowth.

Sensitive skin often causes discomfort, affects many people, especially women and older adults, and should be managed with careful product selection.

The European Society of Cutaneous Lupus Erythematosus created a questionnaire to standardize patient assessment and improve care for cutaneous lupus.

Oral tofacitinib may effectively treat hair loss in children with alopecia areata.

Dapsone improved pustular psoriasis in patients who didn't respond to other treatments and is considered a well-tolerated option.

Some treatments like methotrexate with prednisone might help juvenile morphea, but more research is needed to confirm.

The document concludes that ongoing research using animal models is crucial for better understanding and treating Alopecia Areata.

Most people with Alopecia Areata don't get treatment within a year; it's costly and often comes with other health issues.